Ipca Laboratories (BOM:524494) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524494 Ipca Laboratories Ltd BOM:524494
86 GF Score
Price ₹1,904.30
GF Value ₹1,684.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ipca Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524494
86GF Score
Ipca Laboratories Ltd BOM:524494
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (BOM:524494) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,904.30 is trading 13.1% above its estimated GF Value™ of ₹1,684.26. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for BOM:524494:

  • FFO:
  • GF Value™: ₹1,684.26 vs. price of ₹1,904.30 (13.1% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the BOM:524494 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ipca Laboratories Business Description

Other Exchanges IPCALAB:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
86GF Score

Get the complete analysis for BOM:524494

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,904.30
Price
₹1,684.26
GF Value